Cross-National Trends in Religious Service Attendance.

Public Opin Q

P hilip S. B renner is an assistant professor in the Department of Sociology and a senior research fellow in the Center for Survey Research at the University of Massachusetts Boston, Boston, MA, USA. The author thanks the editors and three anonymous reviewers for their helpful comments and suggestions on previous versions of this manuscript.

Published: May 2016

The nature of religious change and the future of religion have been central questions of social science since its inception. But empirical research on this question has been quite American-centric, encouraged by the conventional wisdom that the United States is an outlier of religiosity in the developed world, and, more pragmatically, by the availability of survey data. The dramatic growth in the number and reach of cross-national surveys over the past two decades has offered a corrective. These data have allowed research on religious trends in the United States, Canada, and Europe, putting American trends into comparative relief. This research synthesis reviews the past quarter century of cross-national comparative survey research on religious behavior, focusing on religious service attendance as a commonly measured behavior that is arguably more equivalent across societies and cultures than other measures of religiosity. The lack of evidence for religious revival is highlighted, noting instead declining rates of attendance in the United States and Canada, and either declining rates or low "bottomed-out" stability in Western Europe, most of Eastern Europe, and Australia and New Zealand. Finally, countries in Latin America, Africa, and Asia are discussed to the extent that research allows, before a call for future research-in these places in particular-is made in order to correct for the Western and Christian focus of much of the research on cross-national religious trends.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888582PMC
http://dx.doi.org/10.1093/poq/nfw016DOI Listing

Publication Analysis

Top Keywords

united states
12
religious service
8
service attendance
8
religious trends
8
states canada
8
declining rates
8
religious
7
cross-national
4
cross-national trends
4
trends religious
4

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Karolinska Institute, Stockholm, Södermanland and Uppland, Sweden.

Background: Novel anti-amyloid therapies (AAT) for Alzheimer's Disease (AD) have recently been approved in the United States, Japan and China, and are under regulatory review in Europe. Questions remain regarding the long-term effectiveness and value of these drugs when used in routine clinical practice. Data from follow-up studies will be important to inform their optimal use, including criteria for treatment initiation, monitoring strategies, stopping rules, pricing and reimbursement considerations.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

ADEL Institute of Science & Technology (AIST), ADEL, Inc., Seoul, Korea, Republic of (South).

Background: The spatiotemporal pattern of the spread of pathologically modified tau through brain regions in Alzheimer's disease (AD) can be explained by prion-like cell-to-cell seeding and propagation of misfolded tau aggregates. Hence, to develop targeted therapeutic antibodies, it is important to identify the seeding- and propagation-competent tau species. The hexapeptide VQIINK of tau is a critical region for tau aggregation, and K280 is acetylated in various tauopathies including AD.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.

Background: In preparation for therapeutic trails involving patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI), there is a need for valid, disease-specific caregiver-reported outcome (CRO) measures capable of tracking symptomatic burden in response to therapy over time. CROs are useful tools in clinical trials for individuals with AD, MCI, and dementia who are unable to self-report. In addition, CROs are accepted by the United States Food and Drug Administration to support regulatory claims.

View Article and Find Full Text PDF

Indirect Detection of the Protons in and around Biradicals and their Mechanistic Role in MAS-DNP.

J Phys Chem Lett

January 2025

National High Magnetic Field Laboratory, Florida State University, 1800 E. Paul Dirac Dr, Tallahassee, Florida 32310, United States.

The contribution of protons in or near biradical polarizing agents in Dynamic Nuclear Polarization (DNP) has recently been under scrutiny. Results from selective deuteration and simulations have previously suggested that the role of protons in the biradical molecule depends on the strength of the electron-electron coupling. Here we use the cross effect DNP mechanism to identify and acquire H solid-state NMR spectra of the protons that contribute to propagation of the hyperpolarization, via an experimental approach dubbed Nuclear-Nuclear Double Resonance (NUDOR).

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Department of Biomedical Engineering, McGill University, Montreal, QC, Canada.

Background: Randomized placebo-controlled trials (RCTs) are the gold standard to evaluate efficacy of new drug treatments for Alzheimer's disease. For example, the United States FDA approved the brain amyloid-targeting drug lecanemab following CLARITY AD, Biogen and Eisai's Phase 3 RCT. However, recruiting enough participants for a high-powered and demographically representative trial is difficult and expensive.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!